Post-partum haemorrhage: beyond the confrontation between misoprostol and oxytocin

Affiliations

Comparative Study

Pierre Buekens et al. Lancet. 2010.

. 2010 Jan 16;375(9710):176-8.

doi: 10.1016/S0140-6736(10)60066-9.

¹ School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA 70112, USA. pbuekens@tulane.edu

No abstract available

Comment on

Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial.
Winikoff B, Dabash R, Durocher J, Darwish E, Nguyen TN, León W, Raghavan S, Medhat I, Huynh TK, Barrera G, Blum J. Winikoff B, et al. Lancet. 2010 Jan 16;375(9710):210-6. doi: 10.1016/S0140-6736(09)61924-3. Epub 2010 Jan 6. Lancet. 2010. PMID: 20060161 Clinical Trial.
Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial.
Blum J, Winikoff B, Raghavan S, Dabash R, Ramadan MC, Dilbaz B, Dao B, Durocher J, Yalvac S, Diop A, Dzuba IG, Ngoc NT. Blum J, et al. Lancet. 2010 Jan 16;375(9710):217-23. doi: 10.1016/S0140-6736(09)61923-1. Epub 2010 Jan 6. Lancet. 2010. PMID: 20060162 Clinical Trial.